Skip to content

Defining the adipose immune environment in PDAC associated cachexia and pre-cachexia weight loss

Defining the adipose immune environment in PDAC associated cachexia and pre-cachexia weight loss - AdipoMap

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035257
Enrollment
50
Registered
2025-04-24
Start date
2023-03-19
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R64

Interventions

Group 1: Control group: Living kidney donors - intraabdominal and subcutaneous adipose tissue was collected intraoperatively Group 2: Pancreatic cancer patients without cachexia (defined by body weigh

Sponsors

Universitätsklinkum Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Suspected pancreatic cancer (for pancreatic cancer groups) - healthy kidney donors (control group) - Written informed consent

Exclusion criteria

Exclusion criteria: - Chronic inflammatory diseases - History of cancer diagnosis

Design outcomes

Primary

MeasureTime frame
Since this is a non-interventional observational study with tissue collection for exploratory purposes, neither primary nor secondary endpoints are defined. The main objective of the study is to characterize local changes in intra-abdominal and subcutaneous adipose tissue in the context of pancreatic cancer-associated cachexia at the single-cell level. A secondary objective is to correlate the obtained results with postoperative weight progression, survival rate, quality of life, and the occurrence of tumor recurrence.

Secondary

MeasureTime frame
Since this is a non-interventional observational study with tissue collection for exploratory purposes, neither primary nor secondary endpoints are defined. The main objective of the study is to characterize local changes in intra-abdominal and subcutaneous adipose tissue in the context of pancreatic cancer-associated cachexia at the single-cell level. A secondary objective is to correlate the obtained results with postoperative weight progression, survival rate, quality of life, and the occurrence of tumor recurrence.

Countries

Germany

Contacts

Public ContactMax Heckler

Universitätsklinkum Heidelberg

max.heckler@med.uni-heidelberg.de+4917643574069

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026